John W. V Umstead, CFO at G1 Therapeutics, holds 187.72K shares in G1 Therapeutics (Ticker: GTHX). Most recently, John W. V Umstead Sold $527 shares of G1 Therapeutics on Jul 08, 2024 for an estimated value of 1.32K.
What is the percentage of profitable transactions made by John W. V Umstead?
The percentage of profitable transactions made by John W. V Umstead is 0%.
What is the average return per transaction made by John W. V Umstead?
The average return per transaction made by John W. V Umstead is -110.30%.
What stocks does John W. V Umstead hold?
John W. V Umstead holds: GTHX stocks.
What was John W. V Umstead’s latest transaction?
John W. V Umstead latest transaction was an Informative Sell of $1.32K.
What was John W. V Umstead's most profitable transaction?
John W. V Umstead’s most profitable transaction was an Informative Sell of GTHX stock on May 15, 2024. The return on the trade was -51.50%.
What is John W. V Umstead's role in G1 Therapeutics?
John W. V Umstead's role in G1 Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.